C07J 41/005
The 17-beta position being substituted by an uninterrupted chain of only two
Official title: {the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives}
C07J41/005 (The 17-beta position being substituted by an uninterrupted chain of only two) appears on 236 US grants and 184 published applications in this corpus.
Search patents in C07J- Granted patents
- 236
- Published applications
- 184
- Assignees
- 129
- Inventors
- 525
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 6 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 6 | 0 |
| 1981 | 9 | 0 |
| 1982 | 1 | 0 |
| 1983 | 5 | 0 |
| 1984 | 5 | 0 |
| 1985 | 4 | 0 |
| 1986 | 7 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 8 | 0 |
| 1991 | 0 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 6 | 0 |
| 1995 | 5 | 0 |
| 1996 | 5 | 0 |
| 1997 | 10 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 2 | 0 |
| 2002 | 0 | 2 |
| 2003 | 1 | 1 |
| 2004 | 3 | 1 |
| 2005 | 2 | 3 |
| 2006 | 1 | 6 |
| 2007 | 5 | 2 |
| 2008 | 2 | 3 |
| 2009 | 3 | 6 |
| 2010 | 1 | 5 |
| 2011 | 0 | 7 |
| 2012 | 1 | 3 |
| 2013 | 7 | 12 |
| 2014 | 3 | 10 |
| 2015 | 4 | 6 |
| 2016 | 5 | 10 |
| 2017 | 7 | 9 |
| 2018 | 8 | 9 |
| 2019 | 9 | 13 |
| 2020 | 7 | 6 |
| 2021 | 5 | 11 |
| 2022 | 6 | 12 |
| 2023 | 7 | 19 |
| 2024 | 7 | 12 |
| 2025 | 10 | 9 |
| 2026 | 4 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof6 Oct 2026US 12,753,204 B2Enanta Pharmaceuticals, Inc.
- Crystal form of 3-hydroxy-5-pregnane-20-one derivative, and preparation method therefor and use thereof15 Sep 2026US 12,735,448 B2TWi Biotechnology, Inc.
- C17, C20, and C21 substituted neuroactive steroids and their methods of use16 Jun 2026US 12,655,175 B2Sage Therapeutics, Inc.
- Small molecule modulators of gut bacterial bile acid metabolism17 Mar 2026US 12,577,273 B2President and Fellows of Harvard College
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Dec 2025US 12,509,487 B2The Texas A&M University System
- Neurosteroids and Prodrugs Thereof24 Sep 2026US 2026/0285897 A1Emory University
- Aminosteroids for the Treatment of a PTP1B Associated Disease20 Aug 2026US 2026/0242409 A1Depymed, Inc.
- Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders30 Apr 2026US 2026/0116913 A1The Texas A&M University System
- Neurosteroid derivative and use thereof23 Apr 2026US 2026/0109731 A1Hunan Mingrui Pharmaceutical Co., Ltd.
- Compositions and methods for treating cns disorders9 Apr 2026US 2026/0098053 A1Sage Therapeutics, Inc.
Most cited
By later US patents
- Oligonucleotide having enhanced binding affinity276US 5,486,603 AGilead Sciences, Inc. · 1996
- Neuroactive steroids of the androstane and pregnane series114US 5,925,630 ACoCensys, Inc. · 1999
- Calicheamicin mimics81US 5,550,246 AThe Scripps Research Institute · 1996
- Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series74US 5,939,545 ACoCensys, Inc. · 1999
- Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series70US 5,232,917 AUniversity of Southern California · 1993